TrialThe oncologist2012

Efficacy, safety, and biomarkers of single-agent bevacizumab therapy in patients with advanced hepatocellular carcinoma.

Valérie Boige et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.